Literature DB >> 19908224

Age-related changes in brain energetics and phospholipid metabolism.

Brent P Forester1, Yosef A Berlow, David G Harper, J Eric Jensen, Nicholas Lange, Michael P Froimowitz, Caitlin Ravichandran, Dan V Iosifescu, Scott E Lukas, Perry F Renshaw, Bruce M Cohen.   

Abstract

Evidence suggests that mitochondria undergo functional and morphological changes with age. This study aimed to investigate the relationship of brain energy metabolism to healthy aging by assessing tissue specific differences in metabolites observable by phosphorus ((31)P) MRS. (31)P MRSI at 4 Tesla (T) was performed on 34 volunteers, aged 21-84, screened to exclude serious medical and psychiatric diagnoses. Linear mixed effects models were used to analyze the effects of age on phosphorus metabolite concentrations, intracellular magnesium and pH estimates in brain tissue. A significant age associated decrease in brain pH (-0.53% per decade), increase in PCr (1.1% per decade) and decrease in PME (1.7% per decade) were found in total tissue, with PCr effects localized to the gray matter. An increase in beta NTP as a function of age (1% per decade) approached significance (p = 0.052). There were no effects demonstrated with increasing age for intracellular magnesium, PDE or inorganic phosphate. This study reports the effects of healthy aging on brain chemistry in the gray matter versus white matter using (31)P MRS measures of high energy phosphates, pH and membrane metabolism. Increased PCr, increased beta NTP (reflecting ATP) and reduced pH may reflect altered energy production with healthy aging. Unlike some previous studies of aging and brain chemistry, this study examined healthy, non-demented and psychiatrically stable older adults and specifically analyzed gray-white matter differences in brain metabolism. 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19908224     DOI: 10.1002/nbm.1444

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  28 in total

1.  Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging.

Authors:  Valerie C Anderson; Ian J Tagge; Xin Li; Joseph F Quinn; Jeffrey A Kaye; Dennis N Bourdette; Rebecca I Spain; Louis P Riccelli; Manoj K Sammi; Charles S Springer; William D Rooney
Journal:  J Neuroimaging       Date:  2020-06-17       Impact factor: 2.486

2.  Effect of altitude on brain intracellular pH and inorganic phosphate levels.

Authors:  Xian-Feng Shi; Paul J Carlson; Tae-Suk Kim; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Seong-Eun Kim; Breanna Glaeser; Kristina Wang; Chun S Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Psychiatry Res       Date:  2014-04-13       Impact factor: 3.222

Review 3.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

4.  Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla.

Authors:  David T Plante; George H Trksak; J Eric Jensen; David M Penetar; Caitlin Ravichandran; Brady A Riedner; Wendy L Tartarini; Cynthia M Dorsey; Perry F Renshaw; Scott E Lukas; David G Harper
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

5.  High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging.

Authors:  Janna L Harris; Hung-Wen Yeh; Russell H Swerdlow; In-Young Choi; Phil Lee; William M Brooks
Journal:  Neurobiol Aging       Date:  2014-01-23       Impact factor: 4.673

Review 6.  Pathways to Brain Aging and Their Modifiers: Free-Radical-Induced Energetic and Neural Decline in Senescence (FRIENDS) Model - A Mini-Review.

Authors:  Naftali Raz; Ana M Daugherty
Journal:  Gerontology       Date:  2017-09-01       Impact factor: 5.140

7.  Tissue-specific differences in brain phosphodiesters in late-life major depression.

Authors:  David G Harper; J Eric Jensen; Caitlin Ravichandran; Yusuf Sivrioglu; Marisa Silveri; Dan V Iosifescu; Perry F Renshaw; Brent P Forester
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

Review 8.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.

Authors:  Zhentao Zhang; Manling Xie; Keqiang Ye
Journal:  Expert Opin Ther Targets       Date:  2016-05-13       Impact factor: 6.902

9.  Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.

Authors:  Zhentao Zhang; Seong Su Kang; Xia Liu; Eun Hee Ahn; Zhaohui Zhang; Li He; P Michael Iuvone; Duc M Duong; Nicholas T Seyfried; Matthew J Benskey; Fredric P Manfredsson; Lingjing Jin; Yi E Sun; Jian-Zhi Wang; Keqiang Ye
Journal:  Nat Struct Mol Biol       Date:  2017-07-03       Impact factor: 15.369

10.  A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression.

Authors:  Brian P Brennan; John Eric Jensen; James I Hudson; Caitlin E Coit; Ashley Beaulieu; Harrison G Pope; Perry F Renshaw; Bruce M Cohen
Journal:  J Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.